| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | 0.0052 | 1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.0044 | 1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0007 | 1 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.00059 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.00049 | 1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.00064 | 1 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.0017 | 1 |